13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0000935836-23-000564
Total Value
$266.2M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | QUIDELORTHO CORP | QDEL | 619,426 | $51.3M | 19.28% |
| 2 | EVOLUS INC | EOLS | 4,506,197 | $32.8M | 12.31% |
| 3 | ADMA BIOLOGICS INC | ADMA | 8,793,321 | $32.4M | 12.19% |
| 4 | GALAPAGOS NV-SPON ADR | GLPGF | 682,664 | $27.8M | 10.43% |
| 5 | AMYLYX PHARMACEUTICALS INC | AMLX | 1,121,028 | $24.2M | 9.08% |
| 6 | MAXCYTE INC | MXCT | 3,966,916 | $18.2M | 6.84% |
| 7 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,500,228 | $14.4M | 5.41% |
| 8 | THIRD HARMONIC BIO INC | 88427A107 | 2,793,149 | $13.4M | 5.05% |
| 9 | ATYR PHARMA INC | ATYR | 4,627,224 | $10.0M | 3.75% |
| 10 | SCYNEXIS INC | SCYX | 2,946,346 | $8.7M | 3.27% |
| 11 | XOMA CORP | XOMAP | 349,399 | $6.6M | 2.48% |
| 12 | REZOLUTE INC | RZLT | 3,072,476 | $6.1M | 2.29% |
| 13 | TELA BIO INC | TELA | 482,619 | $4.9M | 1.84% |
| 14 | UROGEN PHARMA LTD | URGN | 448,508 | $4.6M | 1.74% |
| 15 | EXAGEN INC | XGN | 1,049,352 | $3.0M | 1.14% |
| 16 | GAMIDA CELL LTD | M47364100 | 1,500,000 | $2.9M | 1.09% |
| 17 | ATEA PHARMACEUTICALS INC | AVIR | 752,088 | $2.8M | 1.06% |
| 18 | CASTLE BIOSCIENCES INC | CSTL | 91,978 | $1.3M | 0.47% |
| 19 | AYTU BIOPHARMA INC | AYTU | 472,369 | $755,790 | 0.28% |